| 1,3-Dihydro-4-(2-(dipropylamino)ethyl)-2H-indol-2-one monohydrochloride |
| 2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride |
| 2H-Indol-2-one, 1,3-dihydro-4-(2-(dipropylamino)ethyl)-, monohydrochloride |
| 374R208 |
| 4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochloride |
| 4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride |
| 4-(2-(Dipropylamino)ethyl)indolin-2-onehydrochloride |
| 4-(2-di-n-propylaminoethyl)-2(3H)-indolone hydrochloride |
| 4-(2-di-n-propylaminoethyl)-2(3H)indolone hydrochloride |
| 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one hydrochloride |
| 4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone Hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride |
| 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one hydrochloride |
| 4-[2-(dipropylamino)ethyl]indolin-2-one hydrochloride |
| 4CA-1107 |
| 91374-20-8 |
| 91374-20-8,91374-21-9(freebase) |
| 91374-21-9 (base) |
| 91374-21-9 (Parent) |
| A843815 |
| AB0009822 |
| ABP000199 |
| AC-735 |
| AC-736 |
| AC1L2ABS |
| AC1Q3EQJ |
| ACT02690 |
| Adartrel |
| AK-59618 |
| AKOS015844988 |
| AN-15584 |
| ANW-58872 |
| BC207366 |
| BS-1020 |
| CCG-213346 |
| CHEBI:8889 |
| CHEMBL1200411 |
| CS-2864 |
| CTK8B7890 |
| D00784 |
| D7ZD41RZI9 |
| DTXSID50238533 |
| EBD38503 |
| EU-0101101 |
| FC0024 |
| FT-0642200 |
| HP-3000 |
| HY-B0623A |
| I06-0693 |
| JZP-7 |
| KB-80420 |
| KS-000011L6 |
| KS-00002WRZ |
| LP01101 |
| LS-83828 |
| M-1298 |
| MCULE-8190476072 |
| MFCD01754173 |
| MLS003899234 |
| MolPort-003-987-439 |
| NCGC00094373-01 |
| NCGC00261786-01 |
| NP-201 |
| NVD-434 |
| R 4152 |
| Repreve |
| Requip (TN) |
| ReQuip LP |
| ReQuip PR |
| ReQuip XR |
| Ropinirole (hydrochloride) |
| Ropinirole for peak identification 1, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole for peak identification 2, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole HCl |
| Ropinirole hydrochloride (JAN/USAN) |
| Ropinirole hydrochloride [USAN:USP] |
| Ropinirole hydrochloride [USAN] |
| Ropinirole hydrochloride, EuropePharmacopoeia (EP) Reference Standard |
| Ropinirole Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur |
| Ropinirole hydrochloride, powder, >=98% (HPLC) |
| Ropinirole hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Ropinirole hydrochloride; |
| Ropinirole hydrochloride/ |
| Ropinirolehydrochloride |
| Ropinirolhydrochloride |
| s3189 |
| SCHEMBL40760 |
| SK&F 101468-A |
| SK&F-101468-A |
| SK&F-101468A |
| SKF 101468 hydrochloride |
| SKF 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride |
| SKF-101468A |
| SMR001456484 |
| SR-01000076215 |
| SR-01000076215-2 |
| ST24042825 |
| ST51051236 |
| TC-030791 |
| TL8005858 |
| Tox21_501101 |
| UNII-D7ZD41RZI9 |
| XDXHAEQXIBQUEZ-UHFFFAOYSA-N |
| Z1695926158 |
